// company-profile

Axsome Therapeutics, Inc.

AXSM
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings88Insiders9
// api This Axsome Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 12 insiders purchased shares. Buying was led by Coleman Mark.

// 90-day insight

Over the last 90 days, Axsome Therapeutics, Inc. insiders bought $0 across 17 transactions with no open-market sales.

  • Most active insider: Coleman Mark with 7 transactions totaling $4.2M.
  • Largest single sale: $12.0M by TABUTEAU HERRIOT on Jun 9, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Axsome Therapeutics, Inc. as of 2026-03-31

— stable
Total reported AUM
$5.90B
QoQ change
-2.2%
Reporting period
2026-03-31
#1
BlackRock, Inc.
CIK 2012383
$339.7M
2.0M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
CIK 2100119
$327.5M
1.9M shares
#3
FMR LLC
CIK 315066
$217.1M
1.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026JEFFS ROGERAXSM
Sale10b5
286$249.12$71K
Jun 10, 2026JEFFS ROGERAXSM
Sale10b5
286$246.18$70K
Jun 10, 2026Mahony SusanAXSM
Sale10b5
300$246.18$74K
Jun 10, 2026Coleman MarkAXSM
Sale10b5
643$249.00$160K
Jun 9, 2026Pizzie NickAXSM
Option Exercise10b5
33,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.